<DOC>
	<DOCNO>NCT01970254</DOCNO>
	<brief_summary>The goal clinical research study learn test patient viral infection chemotherapy . Researchers want learn patient high risk infection , future , patient might able test effectively .</brief_summary>
	<brief_title>Widespread v . Selective Screening Hepatitis B Infection Prior Chemotherapy</brief_title>
	<detailed_description>Enrollment Visit : If agree take part study , follow test procedure perform enrollment visit : - Blood ( 1 tablespoon ) drawn test hepatitis B , C , HIV . However , schedule blood draw next 1-2 month , do time . If blood draw do within 90 day enrollment , repeat . - You fill questionnaire risk hepatitis B , C , HIV . You also answer question demographic information age , race , sex . This take 10 minute complete . - If cancer doctor ask information enrollment study , provide cancer team . Study Visit : If test show hepatitis B , C , HIV infection , mail letter result test . If find hepatitis B , C , HIV infection , study staff contact cancer doctor . You receive evaluation medical staff Departments General Internal Medicine , Infectious Diseases , Gastroenterology , Hepatology Nutrition , determine whether need antiviral medication medical care chemotherapy treatment . The study staff inform cancer doctor need antiviral medication . The study staff work closely cancer doctor ( ) avoid delays treatment . You may follow test procedure baseline visit ( 4 week enrollment ) Months 3 , 6 , 9 , 12 , 15 , 18 ( +/- 4 week ) : - If do last 2 week , blood ( 1-2 tablespoon ) draw routine test test hepatitis B . - If doctor think need , ask side effect symptom may . If questionnaire show may contact someone hepatitis B , may contact evaluation medical staff Department General Internal Medicine determine whether need medical care chemotherapy treatment . If doctor think need , blood ( 1-2 tablespoon ) draw follow-up test . Length Study : If one infection , active study participation baseline visit . If hepatitis B , hepatitis C , HIV infection , remain study long benefiting , 12 month chemotherapy treatment end , study close . Researchers may continue check medical record 18 month study enrollment 12 month chemotherapy treatment end . If still receive chemotherapy study close , option continue care study . This investigational study . Researchers investigate whether patient selective patient test hepatitis B , C , HIV . Up 3,441 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>1 . UNKNOWN HBV INFECTION STATUS/ KNOWN HBV INFECTION STATUS MD Anderson patient clinically confirm cancer present first chemotherapy appointment Ambulatory Treatment Center ( ATC ) . 2 . UNKNOWN HBV INFECTION STATUS/ KNOWN HBV INFECTION STATUS Patients &gt; /= 18 year age . ( Patients &lt; 18 year age low risk HBV infection due mandatory HBV vaccination birth . ) 3 . KNOWN HBV INFECTION STATUS Patients evidence HBV infection either : . Patients positive HBsAg antiHBc test perform outside MD Anderson within last 3 month , document result electronic medical record MD Anderson , AND/OR b . Patients currently take medication ( e.g. , lamivudine , entecavir , tenofovir , adefovir , telbivudine , interferon , FDAapproved antihepatitis B drug ) treatment HBV infection . 1 . UNKNOWN HBV INFECTION STATUS Patients positive HBsAg antiHBc test perform outside MD Anderson within last 3 month , document result electronic medical record MD Anderson . 2 . UNKNOWN HBV INFECTION STATUS Patients currently take medication ( e.g. , lamivudine , entecavir , tenofovir , adefovir , telbivudine , interferon , FDAapproved antihepatitis B drug ) treatment HBV infection . 3 . KNOWN HBV INFECTION STATUS Exclusion : None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hepatitis B virus infection</keyword>
	<keyword>HBV</keyword>
	<keyword>Cancer Patients</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>HBV screening strategy</keyword>
	<keyword>HBV care</keyword>
	<keyword>chronic HBV</keyword>
	<keyword>concomitant HBV infection</keyword>
	<keyword>viral infection</keyword>
</DOC>